Related references
Note: Only part of the references are listed.Emergency Department Burden of Constipation in the United States from 2006 to 2011
Thomas Sommers et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2015)
Characterization of gastrointestinal disorders in patients with parkinsonian syndromes
Hyeyoung Park et al.
PARKINSONISM & RELATED DISORDERS (2015)
Liquid Melevodopa Versus Standard Levodopa in Patients With Parkinson Disease and Small Intestinal Bacterial Overgrowth
Alfonso Fasano et al.
CLINICAL NEUROPHARMACOLOGY (2014)
Current and Emerging Pharmacotherapeutic Options for Irritable Bowel Syndrome
Jose L. Barboza et al.
DRUGS (2014)
Nizatidine ameliorates gastroparesis in Parkinson's disease: A pilot study
Hirokazu Doi et al.
MOVEMENT DISORDERS (2014)
Delayed Gastric Emptying in Parkinson's Disease
Sarah Marrinan et al.
MOVEMENT DISORDERS (2014)
Small intestinal bacterial overgrowth in Parkinson's disease
Ai Huey Tan et al.
PARKINSONISM & RELATED DISORDERS (2014)
Elobixibat and its potential role in chronic idiopathic constipation
Andres Acosta et al.
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2014)
The Frequency and Severity of Gastrointestinal Symptoms in Patients with Early Parkinson's Disease
Hye-Young Sung et al.
JOURNAL OF MOVEMENT DISORDERS (2014)
Meta-analysis: antibiotic therapy for small intestinal bacterial overgrowth
S. C. Shah et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2013)
The Relation Between Symptom Improvement and Gastric Emptying in the Treatment of Diabetic and Idiopathic Gastroparesis
Pieter Janssen et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2013)
Short-Chain Carbohydrates and Functional Gastrointestinal Disorders
Susan J. Shepherd et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2013)
Randomized Controlled Phase Ib Study of Ghrelin Agonist, RM-131, in Type 2 Diabetic Women With Delayed Gastric Emptying Pharmacokinetics and pharmacodynamics
Andrea Shin et al.
DIABETES CARE (2013)
An update on current pharmacotherapy options for dyspepsia
Baharak Moshiree et al.
EXPERT OPINION ON PHARMACOTHERAPY (2013)
Gastrointestinal manifestations in Parkinson's disease: prevalence and occurrence before motor symptoms
Maria G. Cersosimo et al.
JOURNAL OF NEUROLOGY (2013)
The role of small intestinal bacterial overgrowth in Parkinson's disease
Alfonso Fasano et al.
MOVEMENT DISORDERS (2013)
A phase 2a, randomized, double-blind 28-day study of TZP-102 a ghrelin receptor agonist for diabetic gastroparesis
N. Ejskjaer et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2013)
Phase 2b, randomized, double-blind 12-week studies of TZP-102, a ghrelin receptor agonist for diabetic gastroparesis
R. W. McCallum et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2013)
Diagnosis and Management of Small Intestinal Bacterial Overgrowth
Matthew Bohm et al.
NUTRITION IN CLINICAL PRACTICE (2013)
Gastrointestinal bacterial overgrowth: pathogenesis and clinical significance
Amit H. Sachdev et al.
THERAPEUTIC ADVANCES IN CHRONIC DISEASE (2013)
Effect of Probiotic or Prebiotic Supplementation on Antibiotic Therapy in the Small Intestinal Bacterial Overgrowth: A Comparative Evaluation
Rosa Rosania et al.
CURRENT CLINICAL PHARMACOLOGY (2013)
Domperidone in Parkinson's Disease: A Perilous Arrhythmogenic or the Gold Standard?
Unax Lertxundi et al.
CURRENT DRUG SAFETY (2013)
Safety and patient outcomes with lubiprostone for up to 52 weeks in patients with irritable bowel syndrome with constipation
W. D. Chey et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2012)
Systematic review: cardiovascular safety profile of 5-HT4 agonists developed for gastrointestinal disorders
J. Tack et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2012)
Coadministration of Domperidone Increases Plasma Levodopa Concentration in Patients With Parkinson Disease
Noriko Nishikawa et al.
CLINICAL NEUROPHARMACOLOGY (2012)
Nizatidine Improves Clinical Symptoms and Gastric Emptying in Patients with Functional Dyspepsia Accompanied by Impaired Gastric Emptying
S. Futagami et al.
DIGESTION (2012)
Plasma levodopa peak delay and impaired gastric emptying in Parkinson's disease
Hirokazu Doi et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2012)
Autonomic involvement in Parkinson's disease: Pathology, pathophysiology, clinical features and possible peripheral biomarkers
Maria G. Cersosimo et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2012)
Placebo-controlled trial of lubiprostone for constipation associated with Parkinson disease
W. G. Ondo et al.
NEUROLOGY (2012)
Azithromycin and the Risk of Cardiovascular Death
Charles A. Knirsch et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Gastroparesis and Parkinson's disease: A systematic review
Zaid S. Heetun et al.
PARKINSONISM & RELATED DISORDERS (2012)
Effect of azithromycin on small bowel motility in patients with gastrointestinal dysmotility
Payam Chini et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2012)
Azithromycin and the Risk of Cardiovascular Death
Wayne A. Ray et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Randomised clinical trial: ghrelin agonist TZP-101 relieves gastroparesis associated with severe nausea and vomiting - randomised clinical study subset data
J. M. Wo et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
Domperidone-Induced Tardive Dyskinesia and Withdrawal Psychosis in an Elderly Woman with Dementia
Jessika Roy-Desruisseaux et al.
ANNALS OF PHARMACOTHERAPY (2011)
Dietary Intake and Nutritional Deficiencies in Patients With Diabetic or Idiopathic Gastroparesis
Henry P. Parkman et al.
GASTROENTEROLOGY (2011)
The importance of non-motor disturbances to quality of life in Parkinson's disease
Pablo Martinez-Martin
JOURNAL OF THE NEUROLOGICAL SCIENCES (2011)
Prevalence of Small Intestinal Bacterial Overgrowth in Parkinson's Disease
Maurizio Gabrielli et al.
MOVEMENT DISORDERS (2011)
The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the Non-Motor Symptoms of Parkinson's Disease
Klaus Seppi et al.
MOVEMENT DISORDERS (2011)
The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the Motor Symptoms of Parkinson's Disease
Susan H. Fox et al.
MOVEMENT DISORDERS (2011)
Diagnosis and treatment of chronic constipation - a European perspective
J. Tack et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2011)
Two Randomized Trials of Linaclotide for Chronic Constipation
Anthony J. Lembo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Rifaximin Therapy for Patients with Irritable Bowel Syndrome without Constipation.
Mark Pimentel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Clinical trial: the combination of rifaximin with partially hydrolysed guar gum is more effective than rifaximin alone in eradicating small intestinal bacterial overgrowth
M. Furnari et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2010)
Domperidone and Ventricular Arrhythmia or Sudden Cardiac Death A Population-Based Case-Control Study in the Netherlands
Charlotte van Noord et al.
DRUG SAFETY (2010)
Linaclotide, through activation of guanylate cyclase C, acts locally in the gastrointestinal tract to elicit enhanced intestinal secretion and transit
Robert W. Busby et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2010)
Small Intestinal Bacterial Overgrowth
Eamonn M. M. Quigley et al.
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA (2010)
Safety and efficacy of ghrelin agonist TZP-101 in relieving symptoms in patients with diabetic gastroparesis: a randomized, placebo-controlled study
N. Ejskjaer et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2010)
Risk of serious ventricular arrhythmia and sudden cardiac death in a cohort of users of domperidone: a nested case-control study
Catherine B. Johannes et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2010)
The multi-herbal drug STW 5 (Iberogast®) has prosecretory action in the human intestine
D. Krueger et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2009)
Gastroparesis: Current diagnostic challenges and management considerations
Shamaila Waseem et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2009)
Small intestinal bacterial overgrowth recurrence after antibiotic therapy
Ernesto C. Lauritano et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
A placebo-controlled trial of prucalopride for severe chronic constipation
Michael Camilleri et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Prevalence of nonmotor symptoms in Parkinson's disease in an international setting; Study using nonmotor symptoms questionnaire in 545 patients
Pablo Martinez-Martin et al.
MOVEMENT DISORDERS (2007)
Macrogol for the treatment of constipation in Parkinson's disease. A randomized placebo-controlled study
Roberta Zangaglia et al.
MOVEMENT DISORDERS (2007)
Lubiprostone, a locally acting chloride channel activator, in adult patients with chronic constipation: a double-blind, placebo-controlled, dose-ranging study to evaluate efficacy and safety
J. F. Johanson et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2007)
Tegaserod in constipation associated with Parkinson disease
John C. Morgan et al.
CLINICAL NEUROPHARMACOLOGY (2007)
Functional bowel disorders
George F. Longstreth et al.
GASTROENTEROLOGY (2006)
Gastric α-synuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology
H Braak et al.
NEUROSCIENCE LETTERS (2006)
Small intestinal bacterial overgrowth: Roles of antibiotics, prebiotics, and Probiotics
EMM Quigley et al.
GASTROENTEROLOGY (2006)
Effect of clarithromycin on the pharmacokinetics of cabergoline in healthy controls and in patients with Parkinson's disease
A Nakatsuka et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2006)
Influence of ghrelin on gastric emptying and meal-related symptoms in idiopathic gastroparesis
J Tack et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2005)
Mosapride citrate, a novel 5-HT4 agonist and partial 5-HT3 antagonist, ameliorates constipation in parkinsonian patients
Z Liu et al.
MOVEMENT DISORDERS (2005)
Influence of erythromycin on gastric emptying and meal related symptoms in functional dyspepsia with delayed gastric emptying
J Arts et al.
GUT (2005)
Increased gastric motility during 5-HT4 agonist therapy reduces response fluctuations in Parkinson's disease
H Asai et al.
PARKINSONISM & RELATED DISORDERS (2005)
Treatment of irritable bowel syndrome with herbal preparations: results of a double-blind, randomized, placebo-controlled, multi-centre trial
A Madisch et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2004)
Oral erythromycin and the risk of sudden death from cardiac causes
WA Ray et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Effect of Tegaserod in Chronic Constipation: A Randomized, Double-Blind, Controlled Trial
John F. Johanson et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2004)
American Gastroenterological Association technical review on the diagnosis and treatment of gastroparesis
HP Parkman et al.
GASTROENTEROLOGY (2004)
Current concepts: Chronic constipation
A Lembo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Basic aspects and pharmacology of probiotics: an overview of pharmacokinetics, mechanisms of action and side-effects
P Marteau et al.
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2003)
Autonomic dysfunction in Parkinson's disease: a comprehensive symptom survey
MF Siddiqui et al.
PARKINSONISM & RELATED DISORDERS (2002)
Share Paper
